TrialSite has covered the rise of research and development in the El Paso region thanks in part to the Medical Center of the Americas Foundation (MCS), a TrialSite partner actively facilitating and supporting the conditions for research expansion in this community of nearly 1 million people. Most recently, the University of Texas at El Paso (UTEP) received a portion of a major $142 million research grant from the Cancer Prevention and Research Institute of Texas (CPRIT). Specifically, Dr. Xuijun “James” Li and his research team were given the High Impact/High-Risk Research Award in the amount of $249,999 for their study in ovarian cancer biomarkers. According to the Cancer Prevention and Research Institute of Texas, Marc Cox was also awarded $5,881,734 for his UTEP partnership with UTMDACC for the study of Hispanic cancer disparities.
First, there is Dr. Li’s research targeting ovarian cancer. This cancer represents the second most common gynecological cancer in the United States, reports Professor Li. The American Cancer Society says that in 2021 alone, 21,410 will receive a new diagnosis of ovarian cancer, and 13,770 will die from ovarian cancer, giving...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).